Navigation Links
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Date:12/9/2009

WALTHAM, Mass., Dec. 9 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) reported today top-line results from a Phase 3 clinical trial to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with a history of pancreatitis. The study's co-primary endpoints were improvements in sensitivity of detection of structural abnormalities of the pancreatic ducts using RG1068 in combination with MRI compared to MRI alone with minimal loss in specificity (<7.5%). The study design used endoscopy as the standard for determination of structural abnormalities. The predetermined criteria for a successful study were achievement of a statistically significant improvement in sensitivity with minimal loss in specificity from two of the three central radiologists reading the MRI images. In this study, one radiologist achieved a statistically significant improvement in sensitivity with RG1068 (p<0.001) while a second radiologist showed a trend but did not achieve statistical significance (p=0.088). There was minimal loss in specificity for all radiologists. While it was not a pre-specified endpoint, pooled data from all three radiologists resulted in a statistically significant improvement in sensitivity with RG1068 (p=0.005) with minimal loss in specificity.

The RG1068-enhanced MRI images showed highly statistically significant improvements on other endpoints for all radiologists including improvements in image quality (p<0.001), ability to see all three segments of the pancreatic duct (p<0.001), and physician confidence in their ability to identify pancreatic duct abnormalities (p<0.001), when compared to MRI alone. There were no serious adverse events (SAEs) associated with the RG1068-MRI procedures compared to 55 SAEs associated
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
2. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
3. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
4. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
5. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
7. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
8. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
9. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
10. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
11. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... June 19, 2013 DST Health Solutions, LLC ... to health plans, integrated delivery systems, and health care ... Drug Management Service (MDMS) has jumped significantly. ... automate the pricing of medical prescription drug claims, MDMS ... automating their medical drug claims processes. As specialty drug ...
(Date:6/19/2013)... 2013   Life Technologies Corporation (NASDAQ: ... granting Suzhou Ribo Life Sciences (Ribo) the exclusive ... China using Life,s Invivofectamine® ... molecules in combination with Invivofectamine® Rx to create ... with high unmet medical need in the Chinese ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... 2011  HeartWare International, Inc. (NASDAQ: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to present at the 23 rd ... a.m. EST on Wednesday, November 30, 2011. The conference ...
... Inc. (NYSE: LDR), will release financial results for the ... December 6, 2011. The company will host ... at 2:00 p.m. Eastern Time. Investors may access the live ... or 480-629-9692 (international callers), or by visiting the "Investors" page ...
Cached Medicine Technology:HeartWare to Present at the 23rd Annual Piper Jaffray Health Care Conference 2Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2011 Results 2
(Date:6/20/2013)... 2013 Creighton University was ... Honor Roll – the highest federal recognition a college ... student- service learning and civic engagement as well as ... Corporation for National and Community Service, is given to ... “Our foundation at Creighton is based on spiritual growth ...
(Date:6/19/2013)... FL (PRWEB) June 20, 2013 Everyone is looking ... fast and inexpensive way to do so. It is called ... regime - only 5 minutes per day - to improve health ... and improves general health. How? , Skin Brushing improves general ... it aids the lymphatic system to drain toxins , ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 Shreya Rangarajan ... the global youth summit on the future of medicine. ... to the Global Youth Summit on the Future of ... Park Country School and the state of Maryland at ... providers will practice in an environment hard to imagine ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 A man returning from ... he used to be. In his debut book titled RED DANCER ... veteran who immerses himself back home, looking for the right place ... De Los Angeles, former marine from the Vietnam War, returns to ... the edge off his PTSD. Wings, a wealthy acquaintance from a ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 According ... clinics, excessive sun exposure is perhaps the ... skin cancer, but that is just one of ... development of skin cancer. Other risk factors include:, ...     Radiation treatment ,     Heredity may play ...
Breaking Medicine News(10 mins):Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 3Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3
... HeartScore the interactive tool designed to predict and help ... Europe created by the European Society of Cardiology (ESC) ... www.HeartScore.org . , This revised version includes relative risk ... and progress monitoring. Three formats are now available to ...
... Ind., Dec. 3 New footage released today from an ... Parenthood staff deliberately violating the state,s mandatory reporting laws for ... footage shows Lila Rose, a UCLA student journalist ... a 13-year-old girl. In an appointment with a Planned Parenthood ...
... Dec. 3 The Coalition for Pulmonary Fibrosis (CPF) today ... to patients and families fighting pulmonary fibrosis (PF), a devastating ... scarring and affecting more than 128,000 Americans. Prevalence and ... 2000 and PF claims 40,000 lives each year - the ...
... part of its continued commitment to,transparency, Cleveland Clinic ... access to timely information about their doctors,professional background, ... , Recently, ... ) a current directory of all its physicians, ...
... Patients, Adds Convenience Through Easy-to-Read Labeling, Standardized O.R. Color-Coding ... 3, Central Admixture Pharmacy Services Inc. (CAPS(R)), a ... that it will introduce a number of advances to ... Beyond-Use-Dating (BUD) and American Society for Testing and Materials ...
... Dec. 3 Cardium Therapeutics,(Amex: CXM ... a webcast providing,an investor presentation, corporate update and ... The webcast will be presented following the close ... can be accessed at, http://www.investorcalendar.com/IC/CEPage.asp?ID=138418 at that ...
Cached Medicine News:Health News:The ESC launches a new release of HeartScore 2Health News:The ESC launches a new release of HeartScore 3Health News:Live Action: New Video Shows Indiana Planned Parenthood Covering Up Rape of 13-year old Girl 2Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 2Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 4Health News:Cleveland Clinic Boosts Transparency, Makes Physician Disclosures Available Online 2Health News:Cleveland Clinic Boosts Transparency, Makes Physician Disclosures Available Online 3Health News:Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008 2Health News:Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008 3Health News:Cardium Announces Investor Presentation and Corporate Update Webcast 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: